Management of a 13-Month-Old Child with Parental GAS and Influenza B Exposure
Do not routinely test or treat the asymptomatic 13-month-old child for either Group A streptococcal infection or influenza B exposure. 1
Group A Streptococcal (GAS) Exposure Management
Household contacts of patients with GAS pharyngitis do not require throat cultures or antimicrobial treatment unless specific high-risk circumstances exist. 1
When NOT to Test or Treat the Child:
- The child is asymptomatic (no fever, sore throat, or systemic symptoms) 1
- The parent has uncomplicated GAS pharyngitis (not invasive disease) 1
- There is no history of recurrent GAS infections in the household 1
- The child has no personal or family history of acute rheumatic fever 1
Exceptions Requiring Consideration of Testing/Treatment:
- Community outbreak of acute rheumatic fever or invasive GAS infection 1
- Family history of acute rheumatic fever 1
- The parent has invasive GAS disease (necrotizing fasciitis, toxic shock syndrome), though data remain limited on routine prophylaxis even in these cases 1
If the Child Develops Symptoms:
Testing for GAS is generally not recommended in children younger than 3 years unless specific risk factors are present, such as an older sibling with documented GAS infection. 1 At 13 months of age, GAS pharyngitis is uncommon, and viral etiologies predominate. 1
If testing is pursued due to concerning symptoms:
- Perform rapid antigen detection test (RADT) with backup throat culture if negative 1
- If positive, treat with amoxicillin 50 mg/kg once daily (maximum 1,000 mg) for 10 days 1
- Alternative: amoxicillin 25 mg/kg twice daily for 10 days 1
Influenza B Exposure Management
Antiviral prophylaxis with oseltamivir is not routinely recommended for household contacts of influenza cases. 1 However, the 13-month-old child represents a high-risk population for influenza complications given age <24 months. 1
Post-Exposure Prophylaxis Considerations:
Oseltamivir prophylaxis (3 mg/kg once daily for 7-10 days) may be considered if:
- The child is unvaccinated or incompletely vaccinated against influenza 1
- Exposure occurred within 48 hours 2
- The child has underlying high-risk conditions (chronic pulmonary disease, cardiac disease, immunosuppression) 1
- Local influenza activity is widespread 1
Dosing for 13-month-old: Oseltamivir 3 mg/kg orally once daily for 7-10 days (based on age 2 weeks to <1 year dosing extrapolated to early toddlers) 2
If the Child Develops Influenza Symptoms:
Treatment with oseltamivir should be initiated immediately without waiting for confirmatory testing if influenza is clinically suspected during periods of community circulation. 1, 2
- Dosing: Oseltamivir 3 mg/kg orally twice daily for 5 days 1, 2
- Initiate within 48 hours of symptom onset for maximal benefit, though treatment beyond 48 hours may still provide benefit in severe disease 1, 2
- Negative rapid influenza tests do not exclude influenza disease 1
Critical Monitoring Parameters:
Watch for signs requiring immediate medical evaluation:
- Fever ≥100.4°F (38°C) with respiratory symptoms (cough, tachypnea, retractions) 1
- Decreased oral intake or signs of dehydration 1
- Lethargy or altered mental status 1
- Respiratory distress (nasal flaring, grunting, retractions) 1
Vaccination Status Verification
Ensure the child's influenza vaccination is up to date. 1 Children 6 months through 8 years receiving influenza vaccine for the first time require 2 doses separated by at least 4 weeks. 1 If the child received only 1 dose previously, a second dose is needed this season. 1
Common Pitfalls to Avoid:
- Do not perform routine throat cultures on asymptomatic household contacts of GAS pharyngitis 1
- Do not delay necessary medical evaluation to complete 48 hours before starting oseltamivir if influenza is suspected 1
- Do not rely solely on rapid antigen tests to exclude influenza; clinical judgment during community outbreaks is paramount 1
- Do not test for GAS in children <3 years with typical viral symptoms (cough, rhinorrhea, conjunctivitis) 1